Enarodustat
- Generic Name
- Enarodustat
- Drug Type
- Small Molecule
- Chemical Formula
- C17H16N4O4
- CAS Number
- 1262132-81-9
- Unique Ingredient Identifier
- JSK7TUA223
- Background
Enarodustat is under investigation in clinical trial NCT02581124 (Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease).
- Indication
适用于非透析的成人慢性肾脏病（CKD）患者的贫血治疗。
SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease
Phase 3
Completed
- Conditions
- Renal Anemia in Non-dialysis Chronic Kidney Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-08-29
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 156
- Registration Number
- NCT06016036
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.
Phase 3
Completed
- Conditions
- Anemia of Chronic Kidney Disease
- Interventions
- First Posted Date
- 2019-07-22
- Last Posted Date
- 2021-03-22
- Lead Sponsor
- JW Pharmaceutical
- Target Recruit Count
- 172
- Registration Number
- NCT04027517
- Locations
- 🇰🇷
SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of
Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
- First Posted Date
- 2015-10-20
- Last Posted Date
- 2016-04-28
- Lead Sponsor
- Akros Pharma Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02581124
Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease
- First Posted Date
- 2013-11-07
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Akros Pharma Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT01978587
Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease
- First Posted Date
- 2013-10-29
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Akros Pharma Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT01971164
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath